Difficulty: Medium
Average Score: 75%
Practice
Which of the following is/are true:
Correct answer
A
Rationale
The correct answer is A) IXIARO is licensed for individuals aged 2 months and older. This statement is true because IXIARO is indeed approved for use in individuals starting from 2 months of age according to the CDC guidelines for Japanese Encephalitis (JE) vaccination.
Option B is incorrect because the recommended schedule for children aged 24 months is actually a single 0.5 ml dose of IXIARO on days 0 and 28. Option C is also incorrect as the primary schedule for IXIARO consists of 2 doses, not 3. Option D is incorrect because primary vaccination should ideally be completed at least 10 days before potential exposure to JE virus, not just one week.
In an educational context, understanding the correct dosing schedule for vaccines like IXIARO is crucial for healthcare professionals to ensure proper administration and protection against infectious diseases like Japanese Encephalitis. This knowledge is vital for nurses, doctors, and other healthcare providers to accurately advise and vaccinate patients, ultimately contributing to effective infection prevention and control practices.
Option B is incorrect because the recommended schedule for children aged 24 months is actually a single 0.5 ml dose of IXIARO on days 0 and 28. Option C is also incorrect as the primary schedule for IXIARO consists of 2 doses, not 3. Option D is incorrect because primary vaccination should ideally be completed at least 10 days before potential exposure to JE virus, not just one week.
In an educational context, understanding the correct dosing schedule for vaccines like IXIARO is crucial for healthcare professionals to ensure proper administration and protection against infectious diseases like Japanese Encephalitis. This knowledge is vital for nurses, doctors, and other healthcare providers to accurately advise and vaccinate patients, ultimately contributing to effective infection prevention and control practices.